Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 4
2017 5
2018 8
2019 5
2020 4
2021 3
2022 5
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Should We Screen HIV-Positive Migrants for Strongyloidiasis?
Theunissen C, Bottieau E, Van Esbroeck M, Tsoumanis A, Florence E. Theunissen C, et al. Among authors: tsoumanis a. Pathogens. 2020 May 18;9(5):388. doi: 10.3390/pathogens9050388. Pathogens. 2020. PMID: 32443596 Free PMC article.
Protocol, rationale and design of BE-PEOPLE (Bedaquiline enhanced exposure prophylaxis for LEprosy in the Comoros): a cluster randomized trial on effectiveness of rifampicin and bedaquiline as post-exposure prophylaxis of leprosy contacts.
Younoussa A, Samidine SN, Bergeman AT, Piubello A, Attoumani N, Grillone SH, Braet SM, Tsoumanis A, Baco A, Mzembaba A, Salim Z, Amidy M, Grillone S, Snijders R, Corstjens P, Ortuno-Gutierrez N, Hoof C, Geluk A, de Jong BC, Hasker E. Younoussa A, et al. Among authors: tsoumanis a. BMC Infect Dis. 2023 May 9;23(1):310. doi: 10.1186/s12879-023-08290-0. BMC Infect Dis. 2023. PMID: 37161571 Free PMC article. Clinical Trial.
High rate of adverse drug reactions with a novel tuberculosis re-treatment regimen combining triple doses of both isoniazid and rifampicin.
Souleymane MB, Kadri S, Piubello A, Tsoumanis A, Soumana A, Issa H, Amoussa AK, Van Deun A, Lynen L, de Jong BC, Decroo T. Souleymane MB, et al. Among authors: tsoumanis a. Int J Infect Dis. 2023 Aug;133:78-81. doi: 10.1016/j.ijid.2023.05.002. Epub 2023 May 5. Int J Infect Dis. 2023. PMID: 37150352 Free article. Clinical Trial.
Effect on the Resistome of Dual vs Monotherapy for the Treatment of Neisseria gonorrhoeae: Results From a Randomized Controlled Trial (ResistAZM Trial).
Thibaut V, Eric F, Christophe VD, Achilleas T, Laumen JGE, Sheeba MS, Saïd A, De Block T, Irith B, Dorien VDB, Yven VH, Anke R, Chris K. Thibaut V, et al. Among authors: achilleas t. Open Forum Infect Dis. 2023 Sep 8;10(10):ofad462. doi: 10.1093/ofid/ofad462. eCollection 2023 Oct. Open Forum Infect Dis. 2023. PMID: 37854109 Free PMC article.
Etiological spectrum of persistent fever in the tropics and predictors of ubiquitous infections: a prospective four-country study with pooled analysis.
Bottieau E, Van Duffel L, El Safi S, Koirala KD, Khanal B, Rijal S, Bhattarai NR, Phe T, Lim K, Mukendi D, Kalo JL, Lutumba P, Barbé B, Jacobs J, Van Esbroeck M, Foqué N, Tsoumanis A, Parola P, Yansouni CP, Boelaert M, Verdonck K, Chappuis F. Bottieau E, et al. Among authors: tsoumanis a. BMC Med. 2022 May 2;20(1):144. doi: 10.1186/s12916-022-02347-8. BMC Med. 2022. PMID: 35491421 Free PMC article.
44 results